Association between metabolic dysfunction-associated fatty liver disease and abdominal aortic aneurysm: findings from the UK Biobank cohort
Abdominal aortic aneurysm (AAA) is the second most common aortic pathological manifestation. Metabolic dysfunction-associated fatty liver disease (MAFLD) has a wide impact on the cardiovascular system and may be a risk factor for AAA. The aim of this study was to investigate whether MAFLD is associated with the risk of AAA.
Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - Category: Nutrition Authors: Yu Jia, Yizhou Li, Jing Yu, Wenli Jiang, Yi Liu, Rui Zeng, Zhi Wan, Xiaoyang Liao, Dongze Li, Qian Zhao Source Type: research
More News: Abdominal Aortic Aneurysm | Aortic Aneurysm | Cardiology | Cardiovascular | Fatty Liver Disease (FLD) | Heart | Liver | Liver Disease | Nutrition | Study | Urology & Nephrology